The news moves fast, but understanding takes time. At Vox, we don’t chase every headline. We focus on what really matters. We break down the biggest stories — and the ones others overlook ...

The news moves fast, but understanding takes time. At Vox, we don’t chase every headline. We focus on what really matters. We break down the biggest stories — and the ones others overlook ...

I wish I could read more of Fosse’s plays. --The Asahi Shimbun, Oct. 12 Vox Populi, Vox Dei is a popular daily column that takes up a wide range of topics, including culture, arts and social ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

The most likely scenario for Hong Kong would be that it would not reopen until China rolls out its mRNA vaccine across its 1.4 billion population, which could take until late 2023 or early 2024 ...

Based on an immunogenicity screen of monkeypox virus (MPXV) surface proteins, the authors develop an mRNA vaccine with 12 antigens, which they combine with T cell epitope-rich regions to achieve ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.